Text book of urinalysis and body fluids A clinical approach Lippincott Ebook PDF download
Text book of urinalysis and body fluids A clinical approach Lippincott Ebook PDF download The science of clinical laboratory hematology provides for the analy-
sis of normal and pathologic peripheral blood cells, hematopoietic (blood-producing) tissue, and the cells in non-vascular body cavities such as cerebrospinal and serous fluids. Laboratory hematology also includes the analysis of the cells and coagulation
proteins essential to clinical hemostasis.
Hematology laboratory assay results are critical for the diagnosis, prognosis, and monitoring treatment for primary and secondary hematologic disor-
ders. Similarly, hematology results are used to establish safety in the perioperative period, monitor treatments during surgical procedures, and monitor transfusion needs in trauma patients.
Clinical laboratory hematology has been enhanced by pro-found changes as reflected in the numerous updates in the fifth edition of Rodak’s Hematology: Clinical Principles and Applications.
Text book of urinalysis and body fluids A clinical approach Lippincott Ebook PDF download and digital data management have revolutionized the way blood specimens are transported and stored, how assays are ordered, and how results are validated, reported, and interpreted.
Text book of urinalysis and body fluids A clinical approach Lippincott Ebook PDF download Molecular diagnosis has augmented and in many instances replaced long-indispensable laboratory assays. Hematologic disorders have been reclassified on the basis of phenotypic, cytogenetic, and molecular genetic analyses. Diagnoses that once depended on the analysis of cell morphology and cytochemical stains now rely on flow ñcytometry, cytogenetic testing, fluorescence in situ hybridization (FISH), end-point and real-time polymerase chain reaction assays, gene sequencing, and microarrays.
Traditional chemotherapeutic monitoring ofof leukemi and lymphomas at the cellular level has shifted to the management of biologic response modifiers and detection of minimal residual disease at the molecular level. Hemostasis has grown to encompass expanded thrombophilia testing, methods that more reliably monitor newly available antiplatenti and anticoagulant drugs, molecular analysis, and a shift
from clot-based to functional and chromogenic assays.